StockMarketWire.com - Goldman Sachs today reaffirms its sell investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 5500p (from 5000p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk